The University of British Columbia
UBC - A Place of Mind
The University of British Columbia
Faculty of Medicine
  • Home
  • Admissions
  • About
    • Strategic Plan
    • Vision & Values
    • Land Acknowledgement
    • Indigenous Health
    • Leadership
    • Academic & Research Units
    • Campuses
    • Facts & Figures
    • Careers
    • Contact
  • News
    • Feature Stories
    • Pathways Magazine
    • The Next Big Question
  • Education
    • Programs
    • Faculty Development
    • Health Education Scholarship
    • Continuing Professional Development
  • Research
    • Priority Areas
    • Canada’s Immuno-Engineering and Biomanufacturing Hub
    • COVID-19 Clinical Research Coordination Initiative
    • Academy of Translational Medicine
    • Edwin S.H. Leong Centre for Healthy Aging
    • Centres & Institutes
    • National Prizes
  • Giving
    • Impact of Giving
    • By the Numbers
    • Ways to Give
    • Webinar Series
    • Contact Us
  • Prospective Students
  • Current Learners
    • Policies & Procedures
    • Respectful Environments, Equity, Diversity & Inclusion
    • Mistreatment Help
    • MD & Undergrad Research
    • Summer Student Research Program
    • Multidisciplinary Research Program in Medicine
    • Grad & Postdoc Education
  • Faculty & Staff
  • Clinical Faculty
    • Becoming Clinical Faculty
    • Appointment Policy & Compensation Terms
    • Teaching Tracking & Payment System
    • Services & Perks
    • Career Development
    • Awards
    • Celebrating Clinical Faculty
    • Advisory Council
    • Contacts
  • Alumni
» Home » News » UBC researchers embark on first-in-Canada study for easing COVID-19 restrictions

Contact

Communications
UBC Faculty of Medicine
Email: communications.med@ubc.ca
Office: 604.822.2421

Support COVID-19 research at UBC

Give Now

UBC researchers embark on first-in-Canada study for easing COVID-19 restrictions

By Camilo Trujillo Sanchez | August 27, 2020

In the midst of a pandemic how can we safely return to work? It’s a question on the minds of employees, employers and policymakers as the world begins the process of re-opening during COVID-19.

Dr. Mel Krajden

Now, in an effort to support decision-making around relaxing restrictions and managing work environments as society reopens, UBC faculty of medicine researchers—Dr. Mel Krajden, Dr. Josef Penninger, and Dr. Simon Pimstone—are collaborating with an inter-sectoral team of industry, academic, and public sector partners in British Columbia to lead a new 15-month, $1.2 million return-to-work study.

The data from the “SARS‐CoV‐2 Study for Eased Restrictions in British Columbia” (SAfER) project, collected in controlled settings, will be available in real time to help inform public health decisions that lead to positive outcomes.

“Effective handling of this pandemic relies on collaboration between public health, academia, and industry to ensure key research is translated into practice,” says Dr. Krajden, professor in the department of pathology and laboratory medicine.

Dr. Josef Penninger

The SAfER study—supported by Genome BC, Genome Canada, and industry partners—will track and collect data over time on infection, immunity, contacts, and clinical symptoms for 1500 volunteer employees at B.C.-based biotechnology companies, including Xenon Pharmaceuticals, STEMCELL Technologies Therapeutics, Zymeworks Inc., as well as UBC and Simon Fraser University. An employee survey will also collect information about stress and anxiety related to the pandemic.

“It is absolutely critical to perform testing to make sure that we can safely re-open. I am very honoured that the Life Sciences Institute at UBC will be a key testing centre, helping to guide the gradual resumption of our activities,” says Dr. Penninger, professor in the department of medical genetics, director of the Life Sciences Institute, and Canada 150 Chair in Functional Genetics.

“It is absolutely critical to perform testing to make sure that we can safely re-open.”
Dr. Josef Penninger, professor in the department of medical genetics

Dr. Simon Pimstone

“No one can solve the challenges around re-opening workplaces on their own. We hope that the type of public-private partnership we are creating with this work can help create a framework for data-driven conversations with all the players at the table,” says study co-lead,” adds Dr. Pimstone, study co-lead and clinical associate professor in the department of medicine.

The breadth of data types collected will also enable integrated data analyses that will reveal trends and predictive markers to inform workplace safety recommendations for COVID-19 and future pandemics.

“The SAfER study will track and collect anonymous data that will provide unique information about the impact of COVID-19 in the workplace and academic research settings,” says Dr. Pascal Spothelfer, President and CEO, Genome BC. “This is one of the first projects of its kind in Canada, and B.C. has a window of opportunity in which to learn and lead as we prepare to meet the coming challenges.”

The SAfER BC study will be supported with testing and tracing partnerships with diagnostics company LifeLabs and app developer Thrive Health. The BC Centre for Disease Control will hold the data and perform the analyses.

A version of this story was originally published on Genome BC.

Contact Information

Communications
UBC Faculty of Medicine
Email: communications.med@ubc.ca
Office: 604.822.2421

Support COVID-19 research at UBC

Donate Online

Faculty of Medicine
317 - 2194 Health Sciences Mall
Vancouver, BC Canada V6T 1Z3
Tel 604 822 2421
Website www.med.ubc.ca
Find us on
    
Back to top
The University of British Columbia
  • Emergency Procedures |
  • Terms of Use |
  • Copyright |
  • Accessibility